Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”

Antonella Fagetti, Roberto E. Mercadillo

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (40)

  1. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  2. Psilocybin occasioned mystical-type experiences. 2020-09-01 · Expand citations
  3. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. 2019-10-24 · Expand citations
  4. Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. 2019-01-01 · Expand citations
  5. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. 2018-01-01 · Expand citations
  6. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. 2017-10-13 · Expand citations
  7. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  8. Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip. 2016-12-01 · Expand citations
  9. A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects 2016-05-24 · Expand citations
  10. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. 2015-11-01 · Expand citations
  11. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
  12. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  13. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  14. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. 2014-01-01 · Expand citations
  15. Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin. 2012-12-01 · Expand citations
  16. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. 2012-03-01 · Expand citations
  17. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  18. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  19. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  20. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  21. Increased activation of indirect semantic associations under psilocybin. 1996-06-15 · Expand citations
  22. Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio). 1971-12-01 · Expand citations
  23. OpenAlex W1967626977
  24. OpenAlex W1987407307
  25. OpenAlex W1992988465
  26. OpenAlex W1993023202
  27. OpenAlex W2034251011
  28. OpenAlex W2042307631
  29. OpenAlex W2108021830
  30. OpenAlex W2111562431
  31. OpenAlex W2124925592
  32. OpenAlex W2135388971
  33. OpenAlex W2140018908
  34. OpenAlex W2168377987
  35. OpenAlex W2168723631
  36. OpenAlex W2744933359
  37. OpenAlex W3012354707
  38. OpenAlex W4231563569
  39. OpenAlex W4242312702
  40. OpenAlex W4243577730

Cited by — these papers cite this paper (2)

  1. Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations
  2. Indigenous psilocybin mushroom practices: An annotated bibliography 2024-02-19 · Expand citations